arundic acid
Small moleculeexperimental
Clinical trial activity
7 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
5
Phase 3
2
Phase 4
0
Earliest trial started Nov 1, 2002 (NCT00046761)
Timeline
2000s
- Jan 1, 2002
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Loading structure…
SMILES
CCCCCC[C@@H](CCC)C(=O)O- Mol. weight
- 186.29 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3187683 ↗
Also known as
- arundic acid
- arundic acid
- mk0724
- ono2506
- ono-2506
- ono-2506
- ono-2506
- (r)-(-)-2-propyloctanoic acid
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00694941 | Phase 2 | Jun 1, 2008 | Ono Pharmaceuticals |
| NCT00401310 | Phase 2 | Jul 1, 2007 | Merck |
| NCT00403104 | Phase 2 | Nov 1, 2006 | Ono Pharmaceuticals |
| NCT00229177 | Phase 2/Phase 3 (Phase 3) | Sep 1, 2005 | Ono Pharmaceuticals |
| NCT00083421 | Phase 2 | Jun 1, 2004 | Ono Pharmaceuticals |
| NCT00212693 | Phase 2 | Jan 1, 2004 | Ono Pharmaceuticals |
| NCT00046761 | Phase 2/Phase 3 (Phase 3) | Nov 1, 2002 | Ono Pharmaceuticals |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ono Pharmaceuticals | For profit | 6 | 6 | 2 | 2002 |
| Merck | For profit | 1 | 1 | 1 | 2007 |
2 organizations
Page 1 / 1